Compare Keysight Technologies Inc (KEYS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Keysight Technologies Inc trades at $329.98 (market cap $53.68B), while State Street SPDR S&P Biotech ETF trades at $154.43. Which is the better fit depends on your goals.
| KEYS | XBI | |
|---|---|---|
Market Cap | $53.68B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $373.34 | $164.28 |
52-Week Low | $158.51 | $85.16 |
Enterprise Value | $54.03B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
